Search

Your search keyword '"Jara-Palomares, L."' showing total 295 results

Search Constraints

Start Over You searched for: Author "Jara-Palomares, L." Remove constraint Author: "Jara-Palomares, L."
295 results on '"Jara-Palomares, L."'

Search Results

1. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

2. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

3. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

4. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

5. COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding

7. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

8. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

9. Timing and characteristics of venous thromboembolism after noncancer surgery

10. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

11. Comparative clinical prognosis of massive and non‐massive pulmonary embolism: A registry‐based cohort study

12. Symptomatic subsegmental versus more central pulmonary embolism: Clinical outcomes during anticoagulation

13. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry

14. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

15. OC 46.1 Absolute Quantitative Proteomics for Occult Cancer Screening in Patient with Unprovoked Venous Thromboembolism: Results from the Prospective PLATO-VTE Study

16. OC 01.2 Oxygen vs Ambient Air in Patients with Intermediate-Risk Acute Pulmonary Embolism: The Air Randomized Clinical Trial

17. PB0479 The ABC-Bleeding Score for Prediction of On-Treatment Clinically Relevant Bleeding in Patients with Unprovoked Venous Thromboembolism: Results from the Prospective PLATO-VTE Study

18. PB1022 MicroRNAs Expression before and after Exercise in Patients with Residual Thrombosis after Pulmonary Embolism

19. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism

21. Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism

22. Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism

23. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

24. The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site

25. Analysis of noncatheter-associated upper extremity deep venous thrombosis from the RIETE registry

26. Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline

27. The risk of recurrent venous thromboembolism after discontinuation of anticoagulant therapy in patients with cancer-associated thrombosis:a systematic review and meta-analysis

28. DVT Management and Outcome Trends, 2001 to 2014

29. A RIETE registry analysis of recurrent thromboembolism and hemorrhage in patients with catheter-related thrombosis

30. A prognostic score to identify low‐risk outpatients with acute deep vein thrombosis in the upper extremity

31. Subsequent arterial ischemic events in patients receiving anticoagulant therapy for venous thromboembolism

32. Incidence and impact of anticoagulation-associated abnormal menstrual bleeding in women after venous thromboembolism

33. Adjusted D-dimer cutoff levels to rule out pulmonary embolism in patients hospitalized for COPD exacerbation: results from de SLICE trial

34. Bleeding risk in hospitalized patients with COVID‐19 receiving intermediate‐ or therapeutic doses of thromboprophylaxis

35. Predicting the risk of cancer after unprovoked venous thromboembolism: external validation of the RIETE score

36. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

39. Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

40. Edoxaban for the Long‐Term Therapy of Venous Thromboembolism: Should the Criteria for Dose Reduction be Revised?

41. [Translated article] Multidisciplinary consensus for the management of pulmonary thromboembolism

42. Major bleeding in patients with pulmonary embolism presenting with syncope

43. Multidisciplinary Consensus for the Management of Pulmonary Thromboembolism

44. Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism

45. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

46. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation

47. Real-Time Dissemination of Aggregate Data on Presentation and Outcomes of Patients With Venous Thromboembolism: The RIETE Infographics Project

48. D-dimer levels and risk of recurrence following provoked venous thromboembolism: findings from the RIETE registry

49. Timing and characteristics of venous thromboembolism after noncancer surgery

50. Predictors of active cancer thromboembolic outcomes

Catalog

Books, media, physical & digital resources